BD Recognized by Forbes as a Best Employer for Diversity in 2023 List

Posted on

Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J., April 25, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the leading employers in the U.S.for diversity.   BD was named to […]

Read More

Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics

Posted on

Oxford Nanopore Technologies and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.  The companies are jointly exploring selected opportunities to advance patient care by providing […]

Read More

ATL Technology Acquires Gyrus Medical LTD. Manufacturing Operations

ATL Technology (ATL), a fast-growing provider of outsourced design, development and manufacturing services to the medical device market, today announced it has acquired manufacturing operations of Gyrus Medical Limited (Gyrus/GML) from Olympus Winter & Ibe GmbH (Olympus Surgical Technologies Europe). Gyrus, located in Cardiff, Wales, United Kingdom, is also a device outsourcer and will increase […]

Read More

Utah State University President, Noelle Cockett, Visits Seek Labs

SALT LAKE CITY, APRIL 27, 2023 – Seek Labs, a healthcare innovation company, welcomed Utah State University (USU) President, Noelle Cockett, at the company’s office on Thursday, April 27. Seek Labs has an ongoing partnership with Utah State University and works closely with President Cockett to advance scientific research at Seek Labs and Utah State. During the […]

Read More

Xenocor Completes Oversubscribed $10 million Series A to Lead the Future of Laparoscopic Visualization

Led by GenHenn Venture Fund I, Xenocor will leverage the capital to facilitate launch and rapid adoption of the 5mm articulating Saberscope SALT LAKE CITY, April 18, 2023 /PRNewswire/ — Xenocor, creator of the FDA cleared Saberscope, the world’s first true HD, fog-free, articulating, single-use laparoscope, announced a $10 million Series A funding led by […]

Read More

New Published Real-World Evidence Shows KidneyIntelX™ Utility

Posted on

Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple Physician Specialties KidneyIntelX individualizes clinical decisions beginning at primary care where impacts of new therapies, blood pressure strategies and timely referral can have maximal effect on outcomes and cost in patients with type 2 diabetes and chronic kidney disease LONDON […]

Read More

Metrodora raises $35M to address neuroimmune disease

Posted on

Originally published in Axios Pro   Instacart CEO Fidji Simo waited three years to be diagnosed with POTS, the condition that led her to cofound the Metrodora Institute, a new outpatient clinical center she’s unveiling with $35 million in corporate venture backing. Why it matters: POTS — postural orthostatic tachycardia syndrome — falls into a […]

Read More

Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

Posted on

Intermountain Precision Genomics Laboratory receives certification from NYS Department of Health Clinical Laboratory Evaluation Program SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of Intermountain Health, are now certified to offer solid tumor testing to […]

Read More

Metrodora Institute Launches to Advance the Treatment of Complex Neuroimmune Diseases and Accelerate the Path to Cures

Posted on

Metrodora is the first integrated, multidisciplinary medical and research center dedicated to diagnosing and treating neuroimmune axis disorders, an under-researched disease space that impacts hundreds of millions of people Institute is building the world’s first biobank and high-density data repository focused on these conditions to inform treatment and serve as the bedrock for future research […]

Read More

bioMérieux receives US FDA 510(k) clearance for the BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini and will apply for CLIA-waiver

Posted on

Marcy-l’Étoile (France), April 13, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the fast and accurate multiplex PCR*-based BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini. bioMérieux will immediately apply for Clinical Laboratory Improvement Amendments (CLIA) waiver for the test. The […]

Read More

PEEL THERAPEUTICS DESCRIBES EXCESSIVE NETOSIS INDUCTION IN LONG COVID

Posted on

Peer-reviewed study offers first description of ongoing NETosis induction in Long COVID; provides insights into pathogenesis and can serve as a surrogate marker for persistent pathology Research emphasizes need to explore neutrophil-targeted therapies in acute and chronic COVID-19 SALT LAKE CITY – April 13, 2023 – Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company, announced research […]

Read More